Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe clinical trial record for the completed FALCON 1 study is now displayed, including its study details, participant criteria, treatment arms, outcome measures, publications, and supporting documents, instead of an error page.SummaryDifference86%

- Check19 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedThe 403 error page was replaced by the ClinicalTrials.gov page shell, which displays an NIH transition notice but no study details.SummaryDifference2%

- Check33 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study record page now renders a 403 Forbidden error, replacing the study content and navigation with a basic error page. This indicates access to the study information at this URL is blocked.SummaryDifference17%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.